Scott Kollins

Professor, Duke University
  • United States of America

Can clinically validated digital therapeutics and rigorous clinical science address longstanding treatment challenges to improving outcomes for children with ADHD?

In spite of dozens of existing treatment options, children with Attention Deficit Hyperactivity Disorder (ADHD) still fare poorly across many domains. We explore a new frontier in which digital therapeutics could help address these challenges for ADHD specifically and mental health more broadly.
Go to the profile of Scott Kollins
Mar 26, 2021